MedAssets (MDAS) Reports In-Line Q4 EPS, FY15 EPS Guidance Misses

MedAssets (NASDAQ: MDAS) reported Q4 EPS of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $198.2 million versus the consensus estimate of $195.3 million.

MedAssets sees FY2015 EPS of $1.13-$1.23, versus the consensus of $1.45. MedAssets sees FY2015 revenue of $753-767 million, versus the consensus of $758.23 million.

For earnings history and earnings-related data on MedAssets (MDAS) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Iridex Corp (IRIX) Misses Q2 EPS by 5c
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance